Longitudinal change in regional brain volumes in prodromal Huntington disease
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: As therapeutics are being developed to target the underlying neuropathology of Huntington disease, interest is increasing in methodologies for conducting clinical trials in the prodromal phase. This study was designed to examine the potential utility of structural MRI measures as outcome measures for such trials. METHODS: Data are presented from 211 prodromal individuals and 60 controls, scanned both at baseline and at the 2-year follow-up. Prodromal participants were divided into groups based on proximity to estimated onset of diagnosable clinical disease: far (>15 years from estimated onset), mid (9-15 years) and near (<9 years). Volumetric measurements of caudate, putamen, total striatum, globus pallidus, thalamus, total grey and white matter and cerebrospinal fluid were performed. RESULTS: All prodromal groups showed a faster rate of atrophy than controls in striatum, total brain and cerebral white matter (especially in the frontal lobe). Neither prodromal participants nor controls showed any significant longitudinal change in cortex (either total cortical grey or within individual lobes). When normal age-related atrophy (ie, change observed in the control group) was taken into account, there was more statistically significant disease-related atrophy in white matter than in striatum. CONCLUSION: Measures of volume change in striatum and white-matter volume, particularly in the frontal lobe, may serve as excellent outcome measures for future clinical trials in prodromal Huntington disease. Clinical trials using white matter or striatal volume change as an outcome measure will be most efficient if the sample is restricted to individuals who are within 15 years of estimated onset of diagnosable disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unified Huntington's disease rating scale: Reliability and consistency
(1996) · Movement Disorders · doi:10.1002/mds.870110204 · Cited by 2,079
Tabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D., Kennard, C., Hicks, S. L., Fox, N. C., Scahill, R. I., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70170-x · Cited by 984
Self-citationLangbehn, D., Brinkman, R., Falush, D., Paulsen, J., Hayden, M., & on behalf of an International Huntington's Disease Collaborative Group (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00241.x · Cited by 817
Self-citationDetection of Huntington's disease decades before diagnosis: the Predict-HD study
Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., Guttman, M., Johnson, S., MacDonald, M., Beglinger, L. J., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.128728 · Cited by 804
Self-citationOnset and rate of striatal atrophy in preclinical Huntington disease
Aylward, E. H., Sparks, B. F., Field, K. M., Yallapragada, V., Shpritz, B. D., Rosenblatt, A., Brandt, J., Gourley, L. M., Liang, K., Zhou, H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000132965.14653.d1 · Cited by 408
Self-citationRosas, H. D., Tuch, D. S., Hevelone, N. D., Zaleta, A. K., Vangel, M., Hersch, S. M., & Salat, D. H. (2006) · Movement Disorders · doi:10.1002/mds.20979 · Cited by 346
Langbehn, D. R., Hayden, M. R., Paulsen, J. S., & and the PREDICT‐HD Investigators of the Huntington Study Group (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30992 · Cited by 338
Self-citationRegional cortical thinning in preclinical Huntington disease and its relationship to cognition
Rosas, H. D., Hevelone, N. D., Zaleta, A. K., Greve, D. N., Salat, D. H., & Fischl, B. (2005) · Neurology · doi:10.1212/01.wnl.0000174432.87383.87 · Cited by 309
Structural MR image processing using the brains2 toolbox
Magnotta, V. A., Harris, G., Andreasen, N. C., O'Leary, D. S., Yuh, W. T. C., & Heckel, D. (2002) · Computerized Medical Imaging and Graphics · doi:10.1016/s0895-6111(02)00011-3 · Cited by 301
Self-citationThe distribution of structural neuropathology in pre-clinical Huntington's disease
Thieben, M. J. (2002) · Brain · doi:10.1093/brain/awf179 · Cited by 272
Harris, G., Andreasen, N. C., Cizadlo, T., Bailey, J. M., Bockholt, H. J., Magnotta, V. A., & Arndt, S. (1999) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199901000-00030 · Cited by 243
Self-citationBasal Ganglia Volume and Proximity to Onset in Presymptomatic Huntington Disease
Aylward, E. H., Codori, A.-M., Barta, P. E., Pearlson, G. D., Harris, G. J., & Brandt, J. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550120105023 · Cited by 188
Self-citationKipps, C. M. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.047993 · Cited by 182
Cortical and striatal neurone number in Huntington's disease
Heinsen, H., Strik, M., Bauer, M., Luther, K., Ulmar, G., Gangnus, D., Jungkunz, G., Eisenmengers, W., & G�tz, M. (1994) · Acta Neuropathologica · doi:10.1007/bf00310376 · Cited by 174
The association of CAG repeat length with clinical progression in Huntington disease
Rosenblatt, A., Liang, K.-Y., Zhou, H., Abbott, M. H., Gourley, L. M., Margolis, R. L., Brandt, J., & Ross, C. A. (2006) · Neurology · doi:10.1212/01.wnl.0000204230.16619.d9 · Cited by 171
Self-citationPowell, S., Magnotta, V. A., Johnson, H., Jammalamadaka, V. K., Pierson, R., & Andreasen, N. C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.05.063 · Cited by 170
Self-citationReading, S. A. J., Yassa, M. A., Bakker, A., Dziorny, A. C., Gourley, L. M., Yallapragada, V., Rosenblatt, A., Margolis, R. L., Aylward, E., Brandt, J., et al. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.05.011 · Cited by 162
Self-citationMotor abnormalities in premanifest persons with Huntington's disease: The PREDICT‐HD study
Biglan, K. M., Ross, C. A., Langbehn, D. R., Aylward, E. H., Stout, J. C., Queller, S., Carlozzi, N. E., Duff, K., Beglinger, L. J., & Paulsen, J. S. (2009) · Movement Disorders · doi:10.1002/mds.22601 · Cited by 146
Self-citationLongitudinal diffusion tensor imaging in Huntington's Disease
Weaver, K. E., Richards, T. L., Liang, O., Laurino, M., Samii, A., & Aylward, E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.12.026 · Cited by 132
Self-citationHobbs, N. Z., Henley, S. M. D., Ridgway, G. R., Wild, E. J., Barker, R., Scahill, R. I., Barnes, J., Fox, N. C., & Tabrizi, S. J. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.190702 · Cited by 130
Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease
Aylward, E. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.028 · Cited by 121
Self-citationRuocco, H. H., Bonilha, L., Li, L. M., Lopes‐Cendes, Í., & Cendes, F. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.116244 · Cited by 120
Onset and Progression of Pathologic Atrophy in Huntington Disease: A Longitudinal MR Imaging Study
Hobbs, N. Z., Barnes, J., Frost, C. D., Henley, S. M. D., Wild, E. J., Macdonald, K. E., Barker, R., Scahill, R. I., Fox, N. C., & Tabrizi, S. J. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2018 · Cited by 113
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease
Aziz, N. A., Jurgens, C. K., Landwehrmeyer, G. B., on behalf of the EHDN Registry Study Group, van Roon‐Mom, W., van Ommen, G. B., Stijnen, T., & Roos, R. A. C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd1121 · Cited by 96
Morphology of the Cerebral Cortex in Preclinical Huntington’s Disease
Nopoulos, P., Magnotta, V. A., Mikos, A., Paulson, H. L., Andreasen, N. C., & Paulsen, J. S. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081266 · Cited by 82
Self-citationEvidence for progression in frontal cortical pathology in late‐stage Huntington's disease
Selemon, L. D., Rajkowska, G., & Goldman, P. S. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10938 · Cited by 74
Basal ganglia volume and clinical correlates in ‘preclinical’ Huntington’s disease
Jurgens, C. K., van de Wiel, L., van Es, A. C. G. M., Grimbergen, Y. A. M., Witjes‐Ané, M. W., van der Grond, J., Middelkoop, H. A. M., & Roos, R. A. C. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0050-4 · Cited by 70
Whole‐brain atrophy as a measure of progression in premanifest and early Huntington's disease
Henley, S. M. D., Wild, E. J., Hobbs, N. Z., Frost, C. D., MacManus, D. G., Barker, R. A., Fox, N. C., & Tabrizi, S. J. (2009) · Movement Disorders · doi:10.1002/mds.22485 · Cited by 65
Wagster, M. V., Hedreen, J. C., Peyser, C. E., Folstein, S. E., & Ross, C. A. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1081 · Cited by 40
Self-citation(2006) · PubMed
Cited by
Huntington's disease: from molecular pathogenesis to clinical treatment
Ross, C. A., & Tabrizi, S. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,743
Self-citationClinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Erkkinen, M. G., Kim, M.-O., & Geschwind, M. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033118 · Cited by 1,124
Huntington disease: natural history, biomarkers and prospects for therapeutics
Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., Scahill, R. I., Leavitt, B. R., Stout, J. C., Paulsen, J. S., et al. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.24 · Cited by 1,016
Self-citationSaudou, F., & Humbert, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.003 · Cited by 951
Tabrizi, S. J., Scahill, R. I., Owen, G., Durr, A., Leavitt, B. R., Roos, R. A., Borowsky, B., Landwehrmeyer, B., Frost, C., Johnson, H., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70088-7 · Cited by 846
Self-citation
Metadata
- Authors
- Aylward, E. H., Nopoulos, P. C., Ross, C. A., Langbehn, D. R., Pierson, R. K., Mills, J. A., Johnson, H. J., Magnotta, V. A., Juhl, A. R., Paulsen, J. S., & the PREDICT-HD Investigators and Coordinators of the Huntington Study Group
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2010-09-30
- Volume
- 82
- Issue
- 4
- Pages
- 405-410
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2031417185
- Cited by
- 252
- References
- 30
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.